Literature DB >> 24014130

Molecular testing for cystic fibrosis carrier status practice guidelines: recommendations of the National Society of Genetic Counselors.

Elinor Langfelder-Schwind1, Barbara Karczeski, Michelle N Strecker, Joy Redman, Elaine A Sugarman, Christina Zaleski, Trisha Brown, Steven Keiles, Amy Powers, Sumheda Ghate, Rebecca Darrah.   

Abstract

PURPOSE: To provide practice recommendations for genetic counselors whose clients are considering cystic fibrosis (CF) carrier testing or seeking information regarding CF molecular test results. The goals of these recommendations are to: 1) Provide updated information about the natural history, diagnosis, and treatment of CF and related conditions. 2) Supplement genetic counselors' knowledge and understanding of the available carrier screening and diagnostic testing options. 3) Describe the current state of genotype/phenotype correlations for CFTR mutations and an approach to interpreting both novel and previously described variants. 4) Provide a framework for genetic counselors to assist clients' decision-making regarding CF carrier testing, prenatal diagnosis, and pregnancy management. Disclaimer The practice guidelines of the National Society of Genetic Counselors (NSGC) are developed by members of the NSGC to assist genetic counselors and other health care providers in making decisions about appropriate management of genetic concerns; including access to and/or delivery of services. Each practice guideline focuses on a clinical or practice-based issue, and is the result of a review and analysis of current professional literature believed to be reliable. As such, information and recommendations within the NSGC practice guidelines reflect the current scientific and clinical knowledge at the time of publication, are only current as of their publication date, and are subject to change without notice as advances emerge.In addition, variations in practice, which take into account the needs of the individual patient and the resources and limitations unique to the institution or type of practice, may warrant approaches, treatments and/or procedures that differ from the recommendations outlined in this guideline. Therefore, these recommendations should not be construed as dictating an exclusive course of management, nor does the use of such recommendations guarantee a particular outcome. Genetic counseling practice guidelines are never intended to displace a health care provider's best medical judgment based on the clinical circumstances of a particular patient or patient population.Practice guidelines are published by NSGC for educational and informational purposes only, and NSGC does not "approve" or "endorse" any specific methods, practices, or sources of information.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24014130     DOI: 10.1007/s10897-013-9636-9

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  67 in total

1.  Cystic fibrosis across Europe: EuroCareCF analysis of demographic data from 35 countries.

Authors:  Gita Mehta; Milan Macek; Anil Mehta
Journal:  J Cyst Fibros       Date:  2010-11-01       Impact factor: 5.482

2.  Best practice guidelines for molecular genetic diagnosis of cystic fibrosis and CFTR-related disorders--updated European recommendations.

Authors:  Els Dequeker; Manfred Stuhrmann; Michael A Morris; Teresa Casals; Carlo Castellani; Mireille Claustres; Harry Cuppens; Marie des Georges; Claude Ferec; Milan Macek; Pier-Franco Pignatti; Hans Scheffer; Marianne Schwartz; Michal Witt; Martin Schwarz; Emmanuelle Girodon
Journal:  Eur J Hum Genet       Date:  2008-08-06       Impact factor: 4.246

Review 3.  The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel.

Authors:  B J Rosenstein; G R Cutting
Journal:  J Pediatr       Date:  1998-04       Impact factor: 4.406

Review 4.  ACOG Committee Opinion No. 486: Update on carrier screening for cystic fibrosis.

Authors: 
Journal:  Obstet Gynecol       Date:  2011-04       Impact factor: 7.661

5.  Cystic fibrosis in pregnancy.

Authors:  Janice E Whitty
Journal:  Clin Obstet Gynecol       Date:  2010-06       Impact factor: 2.190

6.  Impact of IVS8-(TG)m(T)n on IRT and sweat chloride levels in newborns identified by California CF newborn screening.

Authors:  Steven Keiles; Ruth Koepke; Richard Parad; Martin Kharrazi
Journal:  J Cyst Fibros       Date:  2011-12-30       Impact factor: 5.482

7.  Recommendations for the classification of diseases as CFTR-related disorders.

Authors:  C Bombieri; M Claustres; K De Boeck; N Derichs; J Dodge; E Girodon; I Sermet; M Schwarz; M Tzetis; M Wilschanski; C Bareil; D Bilton; C Castellani; H Cuppens; G R Cutting; P Drevínek; P Farrell; J S Elborn; K Jarvi; B Kerem; E Kerem; M Knowles; M Macek; A Munck; D Radojkovic; M Seia; D N Sheppard; K W Southern; M Stuhrmann; E Tullis; J Zielenski; P F Pignatti; C Ferec
Journal:  J Cyst Fibros       Date:  2011-06       Impact factor: 5.482

8.  A tailored approach to family-centered genetic counseling for cystic fibrosis newborn screening: the Wisconsin model.

Authors:  Audrey Tluczek; Christina Zaleski; Dania Stachiw-Hietpas; Peggy Modaff; Craig R Adamski; Megan R Nelson; Catherine A Reiser; Sumedha Ghate; Kevin D Josephson
Journal:  J Genet Couns       Date:  2010-10-09       Impact factor: 2.537

Review 9.  Physiological measurements confirming the diagnosis of cystic fibrosis: the sweat test and measurements of transepithelial potential difference.

Authors:  C J Taylor; J Hardcastle; K W Southern
Journal:  Paediatr Respir Rev       Date:  2009-10-03       Impact factor: 2.726

10.  Genotype-phenotype correlation and frequency of the 3199del6 cystic fibrosis mutation among I148T carriers: results from a collaborative study.

Authors:  K G Monaghan; W E Highsmith; J Amos; V M Pratt; B Roa; M Friez; L L Pike-Buchanan; I M Buyse; J B Redman; C M Strom; A L Young; W Sun
Journal:  Genet Med       Date:  2004 Sep-Oct       Impact factor: 8.822

View more
  7 in total

1.  Introducing the next generation sequencing in genomic amnio and villuos sampling. The so called "Next Generation Prenatal Diagnosis" (NGPD).

Authors:  Claudio Giorlandino; Alvaro Mesoraca; Domenico Bizzoco; Claudio Dello Russo; Antonella Cima; Gianluca Di Giacomo; Pietro Cignini; Francesco Padula; Nella Dugo; Laura D'Emidio; Cristiana Brizzi; Raffaella Raffio; Vincenzo Milite; Lucia Mangiafico; Claudio Coco; Ornella Carcioppolo; Roberto Vigna; Marialuisa Mastrandrea; Luisa Mobili
Journal:  J Prenat Med       Date:  2014 Jan-Mar

Review 2.  Pre- and post-test genetic counseling for chromosomal and Mendelian disorders.

Authors:  Jill Fonda Allen; Katie Stoll; Barbara A Bernhardt
Journal:  Semin Perinatol       Date:  2015-12-21       Impact factor: 3.300

3.  PharmGKB summary: very important pharmacogene information for CFTR.

Authors:  Ellen M McDonagh; John P Clancy; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2015-03       Impact factor: 2.089

Review 4.  Bridging the Gap between Scientific Advancement and Real-World Application: Pediatric Genetic Counseling for Common Syndromes and Single-Gene Disorders.

Authors:  Julie A McGlynn; Elinor Langfelder-Schwind
Journal:  Cold Spring Harb Perspect Med       Date:  2020-10-01       Impact factor: 5.159

5.  Nationwide genetic analysis for molecularly unresolved cystic fibrosis patients in a multiethnic society: implications for preconception carrier screening.

Authors:  Doron M Behar; Ori Inbar; Michal Shteinberg; Michal Gur; Huda Mussaffi; David Shoseyov; Moshe Ashkenazi; Soliman Alkrinawi; Concetta Bormans; Fahed Hakim; Meir Mei-Zahav; Malena Cohen-Cymberknoh; Adi Dagan; Dario Prais; Ifat Sarouk; Patrick Stafler; Bat El Bar Aluma; Gidon Akler; Elie Picard; Micha Aviram; Ori Efrati; Galit Livnat; Joseph Rivlin; Lea Bentur; Hannah Blau; Eitan Kerem; Amihood Singer
Journal:  Mol Genet Genomic Med       Date:  2017-02-19       Impact factor: 2.183

6.  Diseases and Molecular Diagnostics: A Step Closer to Precision Medicine.

Authors:  Shailendra Dwivedi; Purvi Purohit; Radhieka Misra; Puneet Pareek; Apul Goel; Sanjay Khattri; Kamlesh Kumar Pant; Sanjeev Misra; Praveen Sharma
Journal:  Indian J Clin Biochem       Date:  2017-08-22

7.  Problems of Unknown Significance: Counseling in the Era of Next Generation Sequencing.

Authors:  U Fahrioğlu
Journal:  Balkan J Med Genet       Date:  2018-10-29       Impact factor: 0.519

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.